E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
Clinical trial NCT01271504 · COMPLETED
Trial details
- NCT number
- NCT01271504
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-19
- Primary completion
- 2015-06-23
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.